Press Release
[Press Release] ImmuneMed's hzVSF-v13, COVID-19 clinical trials accelerate
development of the treatment
development of the treatment
Writer|
Views |
Date|
| Prev |
[Journal of Clinical Medicine] COVID-19 Phase 2 Clinical Study Results
2022-05-26
|
|---|---|
| Next |
COVID-19 Phase 2 Clinical Study Approval (Italy), December 18th, 2020
2020-12-21
|